“…Over the last decade, the CANTAB has been used in cognitive studies of both neurodegenerative disorders, such as dementia and Huntington's disease (Rahman, Sahakian, Hodges, Rogers, & Robbins, 1999;Sahakian et al, 1990), and psychiatric disorders, such as schizophrenia, MD, and bipolar disorder (Egerhazi et al, 2013;Levaux et al, 2007;Porter, Gallagher, Thompson, & Young, 2003;Roiser & Sahakian, 2013). It has also been used successfully to detect deficits in visuospatial short-term memory in neurosurgical patients with temporal or frontal lobe excision (Owen et al, 1995).…”